SLC36A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.022590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.822300E-02
Normal-vs-Stage2
1.361360E-01
Normal-vs-Stage3
6.870400E-02
Normal-vs-Stage4
7.114400E-01
Stage1-vs-Stage2
2.104200E-01
Stage1-vs-Stage3
5.991000E-01
Stage1-vs-Stage4
9.818000E-02
Stage2-vs-Stage3
1.439380E-01
Stage2-vs-Stage4
3.047600E-01
Stage3-vs-Stage4
7.830400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.819800E-02
Normal-vs-AfricanAmerican
8.947800E-01
Normal-vs-Asian
7.718000E-02
Caucasian-vs-AfricanAmerican
2.270600E-01
Caucasian-vs-Asian
5.885600E-01
AfricanAmerican-vs-Asian
1.930450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.774370E-01
Normal-vs-Female
3.894300E-02
Male-vs-Female
4.777000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.602800E-01
Normal-vs-Age(41-60Yrs)
2.955800E-01
Normal-vs-Age(61-80Yrs)
6.200400E-02
Normal-vs-Age(81-100Yrs)
5.816000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.020400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.765400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.875600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.273900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.602030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.902300E-02
Normal-vs-Daily Drinker
1.412310E-02
Normal-vs-Weekly Drinker
1.957580E-01
Normal-vs-Occasional Drinker
1.404210E-01
Normal-vs-Social Drinker
2.072200E-01
Non Drinker-vs-Daily Drinker
3.556400E-01
Non Drinker-vs-Weekly Drinker
3.500600E-01
Non Drinker-vs-Occasional Drinker
8.839200E-01
Non Drinker-vs-Social Drinker
3.767200E-01
Daily Drinker-vs-Weekly Drinker
6.420300E-02
Daily Drinker-vs-Occasional Drinker
3.428200E-01
Daily Drinker-vs-Social Drinker
7.785700E-02
Weekly Drinker-vs-Occasional Drinker
4.931000E-01
Weekly Drinker-vs-Social Drinker
9.621200E-01
Occasional Drinker-vs-Social Drinker
5.242200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.100400E-01
Normal-vs-Grade 2
1.655780E-01
Normal-vs-Grade 3
2.150000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.320300E-03
Grade 1-vs-Grade 3
2.098100E-02
Grade 1-vs-Grade 4
6.100400E-01
Grade 2-vs-Grade 3
7.057800E-01
Grade 2-vs-Grade 4
1.655780E-01
Grade 3-vs-Grade 4
2.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.040300E-02
Normal-vs-NonDiabetic
7.570500E-02
Diabetic-vs-NonDiabetic
9.976400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.143900E-02
Normal-vs-NoPancreatitis
9.003800E-02
Pancreatitis-vs-NoPancreatitis
7.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.424000E-02
Normal-vs-N1
1.581230E-01
N0-vs-N1
9.978300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.455990E-01
Normal-vs-TP53-NonMutant
2.832000E-01
TP53-Mutant-vs-TP53-NonMutant
6.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
